ARTICLE | Distillery Therapeutics
Cancer
September 20, 2018 3:20 PM UTC
Cell culture and mouse studies suggest promoting phagocytosis mediated by CALR-asialoglycan binding could help treat colorectal cancer and leukemia. In two human colorectal cancer and two human leukem...
BCIQ Company Profiles
BCIQ Target Profiles